This inventor holds 1 USPTO granted patent. Top assignee: Bionavis Ltd.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Vesa Kleimola: Innovator in Diagnostic Methods
Introduction
Vesa Kleimola is a notable inventor based in Turku, Finland. He has made significant contributions to the field of diagnostic methods, particularly in the development of non-invasive techniques for detecting infections. His innovative approach has the potential to enhance the accuracy and efficiency of medical diagnostics.
Latest Patents
Vesa Kleimola holds a patent related to diagnostic methods. The patent focuses on novel non-invasive methods for the detection of the presence or absence of an antigen or a metabolite produced by bacteria in biological samples using biosensor-based measurements. This invention also involves the use of a biosensor containing specific antibodies or antigen-binding fragments immobilized on it, along with biomolecule-repellent polymers to prevent non-specific binding. Additionally, the invention includes test kits that are useful in these diagnostic methods.
Career Highlights
Vesa Kleimola is associated with Bionavis Ltd., a company that specializes in biosensor technology. His work at Bionavis has allowed him to explore and develop innovative solutions in the field of diagnostics. His contributions have been instrumental in advancing the capabilities of biosensor applications in medical diagnostics.
Collaborations
Vesa Kleimola has collaborated with notable colleagues such as Erkki Eerola and Markku Viander. These collaborations have fostered a productive environment for innovation and have contributed to the development of cutting-edge diagnostic technologies.
Conclusion
Vesa Kleimola's work in diagnostic methods exemplifies the impact of innovation in healthcare. His patented technologies have the potential to revolutionize the way infections are diagnosed, making significant strides in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile